Sylvie Berger

525 total citations
20 papers, 348 citations indexed

About

Sylvie Berger is a scholar working on Molecular Biology, Endocrine and Autonomic Systems and Organic Chemistry. According to data from OpenAlex, Sylvie Berger has authored 20 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Endocrine and Autonomic Systems and 4 papers in Organic Chemistry. Recurrent topics in Sylvie Berger's work include Circadian rhythm and melatonin (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Coenzyme Q10 studies and effects (3 papers). Sylvie Berger is often cited by papers focused on Circadian rhythm and melatonin (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Coenzyme Q10 studies and effects (3 papers). Sylvie Berger collaborates with scholars based in France, Belgium and Estonia. Sylvie Berger's co-authors include Gilles Ferry, Jean A. Boutin, Philippe Delagrange, Saı̈d Yous, Francis Cogé, Yannis Karamanos, Gérald Guillaumet, Raymond Julien, Natacha Moulharat and Sophie‐Pénélope Guenin and has published in prestigious journals such as PLoS ONE, Archives of Biochemistry and Biophysics and Biochemical Pharmacology.

In The Last Decade

Sylvie Berger

19 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Berger France 10 160 127 62 46 42 20 348
Katarzyna Walczak Poland 15 312 1.9× 58 0.5× 92 1.5× 28 0.6× 7 0.2× 26 805
Shuqing Zhang China 14 171 1.1× 42 0.3× 28 0.5× 27 0.6× 14 0.3× 36 452
M Brungs Germany 6 181 1.1× 170 1.3× 47 0.8× 48 1.0× 13 0.3× 7 451
María C. Moreno Argentina 14 233 1.5× 58 0.5× 10 0.2× 79 1.7× 8 0.2× 25 520
Ching‐Han Yu Taiwan 13 232 1.4× 120 0.9× 118 1.9× 63 1.4× 31 0.7× 30 573
Thuy-Anh Tran United States 11 206 1.3× 114 0.9× 105 1.7× 50 1.1× 35 0.8× 15 378
Yue Cui China 18 356 2.2× 33 0.3× 24 0.4× 38 0.8× 8 0.2× 43 648
E. Philip Jesudason India 13 149 0.9× 40 0.3× 62 1.0× 22 0.5× 10 0.2× 13 413
Manika Pal Bhadra India 9 143 0.9× 80 0.6× 211 3.4× 17 0.4× 14 0.3× 13 428

Countries citing papers authored by Sylvie Berger

Since Specialization
Citations

This map shows the geographic impact of Sylvie Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Berger more than expected).

Fields of papers citing papers by Sylvie Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Berger. The network helps show where Sylvie Berger may publish in the future.

Co-authorship network of co-authors of Sylvie Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Berger. A scholar is included among the top collaborators of Sylvie Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Berger. Sylvie Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Berger, Sylvie, et al.. (2023). An efficient site-selective, dual bioconjugation approach exploiting N-terminal cysteines as minimalistic handles to engineer tailored anti-HER2 affibody conjugates. European Journal of Medicinal Chemistry. 260. 115747–115747. 2 indexed citations
3.
Fejes, Imre, Melinda Sipos, Zoltán Sipos, et al.. (2022). Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline Mimetics. ACS Medicinal Chemistry Letters. 13(6). 949–954. 8 indexed citations
4.
Baló, Tímea, Á.Z. Kiss, Eric Raimbaud, et al.. (2022). Synthesis of thieno[2,3-c]pyridine derived GRK2 inhibitors. Monatshefte für Chemie - Chemical Monthly. 154(12). 1339–1357. 4 indexed citations
5.
Berger, Sylvie, Agnès Chomel, Kai Kisand, et al.. (2021). S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseases. Journal of Translational Autoimmunity. 4. 100093–100093. 2 indexed citations
6.
Olivon, Florent, Louis‐Félix Nothias, Vincent Dumontet, et al.. (2018). Natural Inhibitors of the RhoA–p115 Complex from the Bark ofMeiogyne baillonii. Journal of Natural Products. 81(7). 1610–1618. 9 indexed citations
7.
8.
Berger, Sylvie, Déborah Harrus, Catherine Dacquet, et al.. (2015). Molecular mechanisms of transcriptional control by Rev‐erbα: An energetic foundation for reconciling structure and binding with biological function. Protein Science. 24(7). 1129–1146. 9 indexed citations
9.
Bodmer, Alexandre, et al.. (2015). P241 Usefulness of the 21-gene assay to guide adjuvant chemotherapy decision-making: Geneva experience. The Breast. 24. S108–S108. 2 indexed citations
10.
Berger, Sylvie, Céline Legros, Jean‐Louis Banères, et al.. (2014). Recombinant Human Melatonin Receptor MT1 Isolated in Mixed Detergents Shows Pharmacology Similar to That in Mammalian Cell Membranes. PLoS ONE. 9(6). e100616–e100616. 19 indexed citations
11.
Ferry, Gilles, Sylvie Berger, Natacha Moulharat, et al.. (2010). Old and new inhibitors of quinone reductase 2. Chemico-Biological Interactions. 186(2). 103–109. 42 indexed citations
12.
Boutin, Jean A., Philippe Hennig, Natacha Moulharat, et al.. (2008). MT3/QR2 melatonin binding site does not use melatonin as a substrate or a co‐substrate. Journal of Pineal Research. 45(4). 524–531. 33 indexed citations
13.
Boutin, Jean A., Sophie‐Pénélope Guenin, Sylvie Berger, et al.. (2008). Studies of the melatonin binding site location onto quinone reductase 2 by directed mutagenesis. Archives of Biochemistry and Biophysics. 477(1). 12–19. 13 indexed citations
14.
Mailliet, François, Gilles Ferry, F Vella, et al.. (2005). Characterization of the melatoninergic MT3 binding site on the NRH:quinone oxidoreductase 2 enzyme. Biochemical Pharmacology. 71(1-2). 74–88. 97 indexed citations
15.
Ceuninck, Frédéric De, Sylvie Berger, Martine Raes, et al.. (2005). Assessment of some tools for the characterization of the human osteoarthritic cartilage proteome.. PubMed. 16(3). 256–65. 43 indexed citations
16.
Ferry, Gilles, Claire Dauly, Julien Mozo, et al.. (2004). Purification of the recombinant human serotonin N-acetyltransferase (EC 2.3.1.87): further characterization of and comparison with AANAT from other species. Protein Expression and Purification. 38(1). 84–98. 14 indexed citations
17.
L’Hôte, Corine, Sylvie Berger, & Yannis Karamanos. (1996). O-glycosylation of Fibrinogen from Different Mammalian Species as Revealed by the Binding of Escherichia coli Biotinylated Lectins. Thrombosis and Haemostasis. 76(5). 710–714. 7 indexed citations
18.
19.
Berger, Sylvie, Yannis Karamanos, Françoise Schoentgen, & Raymond Julien. (1994). Characterization and use of biotinylated Escherichia coli K99 lectin. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1206(2). 197–202. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katarzyna Walczak Breakdown of academic impact, for papers by Shuqing Zhang Breakdown of academic impact, for papers by M Brungs Breakdown of academic impact, for papers by María C. Moreno Breakdown of academic impact, for papers by Ching‐Han Yu Breakdown of academic impact, for papers by Thuy-Anh Tran Breakdown of academic impact, for papers by Yue Cui Breakdown of academic impact, for papers by E. Philip Jesudason Breakdown of academic impact, for papers by Manika Pal Bhadra
Rankless by CCL
2026